Benefits of Oxford/AstraZeneca vaccine 'firmly outweigh any risk', says EMA director – video

The EMA is conducting an investigation into the safety of AstraZeneca's Covid-19 vaccine after Germany, France, Italy and other EU countries suspended its use over isolated cases of bleeding, blood clots and low platelet counts.

Director Emer Cooke stated the EMA is "still firmly convinced the benefits of the AstraZeneca vaccine ... outweigh the risk of these side effects." The investigative panel will meet again on Thursday when they will publish their findings to the public.

• Europe's caution over Oxford vaccine about more than the science